SEC 13F Intelligence

Bayesian Capital Management, LP / AMGN

Bayesian Capital Management, LP’s Amgen Inc Position

Does Bayesian Capital Management, LP own Amgen Inc (AMGN)? Not currently — the last reported position was 43.0K shares worth $11M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$11M
Q4 2024
Shares
43.0K
% of Portfolio
+1.37%
Quarters Held
9
position exited

Position History AMGN

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q4 ’19: $212,000Q1 ’22: $1MQ1 ’22Q1 ’23: $1MQ2 ’23: $4MQ2 ’23Q3 ’23: $4MQ1 ’24: $2MQ1 ’24Q2 ’24: $4MQ4 ’24: $11MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202443.0K$11M+1.37%
Q2 202412.0K$4M+0.43%
Q1 20247.3K$2M+0.20%
Q3 202316.4K$4M+0.50%
Q2 202318.4K$4M+0.44%
Q1 20234.9K$1M+0.15%
Q1 20224.3K$1M+0.16%
Q4 2019880$212,000+0.04%
Q4 20189.9K$2M+0.39%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bayesian Capital Management, LP’s full portfolio or all institutional holders of AMGN.